Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Pediatrics/Neonatology | Vaccines
Disease Category: Vaccines
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

Preventative vaccine

Purpose

Winthrop University Hospital Department of Pediatric Infectious Disease is seeking healthy children 6 to <24 months of age for a medical research study. Testing a vaccine to prevent Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) which are causes of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in infants and young children.

Eligible participants will receive study-related medical exams, laboratory testing, and study vaccine at no cost. You do not need health insurance to participate and compensation for time and travel may be provided.

Main inclusion criteria:

  • Between the ages of 6 and 24 months of age and healthy
  • Willing to frequently travel to the study doctor’s office for study visits

To Learn more
Phase

1

Gender

Both Male and Female

Age

6 to 24 Months

Overall Status

Recruiting

Facility Type

N/A

Contact

Ann Mock, RN CCRC, RN, Pediatric Research Coordinator
Winthrop University Hospital Clinical Trials Center
259 First Street
Mineola, NY 11501
Phone: 516-663-9619
Fax: 516-663-4698

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 154294

Date Last Changed: July 24, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.